Unlocking the Secrets of Severe Asthma: From Pathways to Precision is the launch of the brand new reelCE™ initiative, designed to educate U.S.-based pulmonologists, allergists, nurse practitioners, and physician associates through an engaging micro-video CE series.
This social media-based CE explores key topics in severe asthma (SA), including pathophysiology, treatment modalities, exacerbation management, emerging therapies, and translating recent evidence into practice. Addressing critical gaps in SA care, the series highlights challenges such as delayed diagnoses, underuse of biologics, non-adherence due to complex regimens, healthcare disparities, and overlooked psychosocial factors.
By partnering with well-known content creators and leveraging the power of social media algorithms and to reach a wider audience of HCPs, this engaging format is designed to enhance clinical skills and promotes better treatment decisions and ultimately improving patient outcomes.
Speakers
Karina Cañadas, MD, MBA
Otolaryngologist
Head and Neck Surgeon
Houston, TX, USA
Dr. Karina Cañadas is an Ivy League-trained, board-certified ENT and fellowship-trained pediatric ENT, providing exceptional medical care for all ages. Fluent in English and Spanish, she is known for her compassionate approach and dedication to patient education.
After earning her medical degree from Georgetown University, Dr. Cañadas completed her ENT surgery training at Yale-New Haven Hospital, where she was inducted into the prestigious Gold Humanism Honor Society for her patient advocacy. She then completed a pediatric ENT fellowship at Baylor College of Medicine and Texas Children’s Hospital, where she remained on faculty for nine years.
An inquisitive mind always seeking medical advancements, Dr. Cañadas has authored multiple peer-reviewed publications and maintains a vast network of specialists to ensure comprehensive, multidisciplinary care. Passionate about simplifying patient education, Dr. Cañadas developed engaging, multilingual educational videos, making complex medical concepts accessible to all. Her entrepreneurial spirit and commitment to innovation continue to transform patient care.
Dr. Cañadas currently has a concierge ENT practice in Houston, Texas and is also a social media health influencer by the name of @teach_me_doc.
Bio in Full - https://mdondelivery.com/about-us
Payel Gupta, MD, FACAAI
Medical Director
Tono Health and Ease Allergy
Brooklyn, NY, USA
Dr. Payel Gupta is a triple board-certified Allergist & Immunologist. She is an Assistant Clinical Professor at SUNY Downstate Medical Center and a clinical instructor at Mt. Sinai Medical Center in New York City. She is the Medical Director of Allergy, Asthma & Immunology at Tono Health and also owner of Ease Allergy in Brooklyn, NY.
She treats both adult and pediatric patients with asthma, environmental allergies, allergic skin conditions, immune disorders and food allergies. She is Co-Host on The Itch Podcast (www.itchpodcast.com), a podcast dedicated to helping patients understand their allergic conditions. She is past president of the New York Allergy & Asthma Society, a Volunteer National Spokesperson for the American Lung Association and is an active member of the American College of Allergy, Asthma and Immunology and American Academy of Allergy, Asthma and Immunology.
M. Waseem Imam, DO
CMO
Cure Allergy Clinic
Arlington, TX, USA
Dr. M. Waseem Imam was born in Boston, Massachusetts, and spent most of his childhood in the suburbs of Detroit, Michigan. He has a Bachelor of Psychology from Wayne State University and a Master of Biomedical Sciences from Midwestern University. He earned his medical degree from Lincoln Memorial University. Dr. Imam is Board Certified in Allergy, Asthma, and Immunology for Pediatrics and Adults. He is also Board Certified in Internal Medicine and Obesity Medicine. Dr. Imam was nominated as
a Fellow with the American College of Allergy, Asthma, and Immunology. His area of focus includes inhalant and food allergies, asthma, desensitization therapy to retrain the immune system, allergen immunotherapy, and sublingual immunotherapy. Dr. Imam is passionate about helping his patients live free of allergies. He founded Cure Allergy Clinic because he believed a personal touch was needed in healthcare and wanted to help patients reach customized solutions for their concerns. He is also an adjunct professor of medicine with the UNTHSC Internal Medicine program in Arlington, TX as well as an assistant professor of medicine with TCU School of Medicine
Farah Khan, MD, MS
Allergist/Immunologist
Assistant Professor of Pediatrics
Nationwide Children’s Hospital
The Ohio State University
College of Medicine
Columbus, OH, USA
Farah Khan, MD, is a board-certified allergist/immunologist born and raised in DC. She completed her pediatric residency at Inova Children’s Hospital in Fairfax, VA followed by Allergy/Immunology fellowship at Virginia Commonwealth University. She worked in private practice for a couple of years in Vienna, VA before joining Nationwide Children’s Hospital in Columbus, Ohio in 2022. Her clinical interested include drug allergy delabeling, food allergy, asthma, and digital health.
Juanita Mora, MD
CEO/Physician
Chicago Allergy Center
Chicago, IL, USA
Juanita Mora, MD, is a highly accomplished physician and leader in the field of allergy and immunology. With a passion for improving the lives of patients, she has dedicated her career to providing exceptional medical care and advocating for lung health.
Driven by her passion for medicine, she obtained her Medical Doctorate Degree from the University of Illinois at Chicago College of Medicine. She completed her Internal Medicine and Pediatrics residency program, as well as an Allergy and Immunology Fellowship, at Rush University Medical Center. She also received a Master of Clinical Research degree from Rush University Medical Center. Dr. Mora currently serves as a Physician and CEO at the Chicago Allergy Center. Since 2014, she has been instrumental in managing the center while also delivering personalized care to her patients.
In addition to her clinical work, Dr. Mora has served as a National Volunteer Medical Spokesperson for the American Lung Association since 2018 and has become a highly sought-after expert in the field. She has been featured on various prominent media outlets, including NBC Nightly News with Lester Holt, The New York Times, CNN, USA Today and NPR. Through these interviews, she has effectively conveyed vital information to the public, debunking misconceptions, and providing accurate insights on young vaping, tobacco cessation, the health impacts of poor air quality, asthma, RSV and other respiratory conditions. She also joined the American Lung Association’s National Board on June 24, 2023.
Dr. Juanita Mora's commitment to providing exceptional medical care and promoting lung health has made a significant impact on the healthcare community. Her expertise and dedication continue to positively influence the lives of her patients and the broader community she serves
Accreditation and Disclosure Information
Target Audience
This activity is designed for physicians, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals specializing in pulmonology and allergy on the multidisciplinary, interprofessional healthcare team in the U.S. who diagnosis and treat patients with severe asthma (SA).
Learning Objectives
After completing this activity, the participant should be better able to:
- Distinguish severe asthma from other respiratory conditions
- Integrate target biologics into treatment plans by identifying eligible patient populations considering clinical phenotype, biomarker data, and comorbidities
- Implement strategies to overcome barriers to optimal care in severe asthma
Agenda
- Is Your Patient’s Asthma Truly Severe or Just Mismanaged?
- What are the Signs of Severe Asthma?
- Is Your Asthma Diagnosis Missing the Mark?
- What is the Role of Type 2 Inflammation in Severe Asthma?
- How Do Biomarkers Fuel Eosinophilic Inflammation in Severe Asthma?
- Are Biomarkers the Missing Link in Unlocking Asthma Care?
- Will Biologics Revolutionize Severe Asthma Treatment?
- What Can Key Clinical Trials Teach Us About Biologics in Severe Asthma?
- How Do You Choose the Right Biologic for Severe Asthma?
- Why are Healthcare Disparities Leaving Asthma Patients Behind?
- How Do Geography and SES Impact Asthma?
- Can We Bridge the Gap in Asthma Disparities?
- How Can You Navigate the Biologic Maze for Severe Asthma Treatment?
- How Can You Help Your Patients Manage Insurance for Asthma Biologics?
- How Can You Keep Patients Committed to Their Asthma Treatment?
Accreditation, Support and Credit
This activity is provided by MLI
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
PA
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until May 15, 2026. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 0.33 contact hour in the area of pharmacology.
Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
UAN: JA0007322-0000-25-014-H01-P
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks, view your participation record at the NABP website: https://nabp.pharmacy/
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Support Statement
This educational activity is supported by an independent medical education grant from GSK.
Disclosure & Conflict of Interest Policy
Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Chair/Planner
Tonia Farmer, MD
ENT Independent Medical Provider
Founder, Dr. Nose Best® Wellness
On-Air Medical Expert, 21 WFMJ News Station
Chief Medical Ambassador, Nampons
Warren, OH, USA
Tonia Farmer, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Planner/Presenter
Karina Cañadas, MD, MBA
Otolaryngologist
Head and Neck Surgeon
Houston, TX, USA
Karina Canadas, MD, MBA, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Planner/Presenter
Payel Gupta, MD
Medical Director
Tono Health and Ease Allergy
Brooklyn, NY, USA
Payel Gupta, MD, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: ALK, Genentech, Novartis, Regeneron, Sanofi
Planner/Presenter
M. Waseem Imam, DO
CMO
Cure Allergy Clinic
Arlington, TX, USA
M. Waseem Imam, DO, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor/Speaker: AstraZeneca
Planner/Presenter
Farah N. Khan, MD, MS
Allergist/Immunologist
Assistant Professor of Pediatrics
Nationwide Children’s Hospital
The Ohio State University College of Medicine
Columbus, OH, USA
Farah Khan, MD, has a financial interest/relationship or affiliation in the form of:
Stocks: Doximity
Planner/Presenter
Juanita Mora, MD
CEO/Physician
Chicago Allergy Center
Chicago, IL, USA
Juanita Mora, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute Inc, the accredited provider, does not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute Inc.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact MLI at mvu@mlieducation.org.
About This Activity
Medical Learning Institute Inc is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.
Resources
Downloadable resources are found within the lesson.